期刊文献+

我院“医改”后2013年1-5月门诊药房处方点评情况与不合理处方分析 被引量:5

Analysis of Outpatient Pharmacy Prescription Review and Unreasonable Prescriptions in Our Hospital after Medical Reform from Jan. to May in 2013
原文传递
导出
摘要 目的:对某院"医改"后2013年1-5月门诊药房处方点评结果进行分析,以提高医院合理用药水平。方法:根据《处方管理办法》《医院处方点评管理规范(试行)》等,抽取该院2013年1-5月中每月第1个连续5个工作日的门诊处方,采取处方四级点评、四级反馈的模式,对不合理用药处方进行分析,并提出建议。结果:共抽取处方186 944张,不合理处方总数为648张,平均处方合理率为99.65%,与"医改"前(2012年7-11月)平均处方合理率93.18%比较,处方合理率显著提高,差异有统计学意义(P<0.05);主要不合理用药类型为适应证不适宜(25.37%)、用法用量不适宜(48.70%)。结论:"医改"后该院处方合理率明显提高,但仍应继续通过多种措施加强对不合理处方的干预,进一步提高该院合理用药水平。 OBJECTIVE : To improve the level of rational drug use in a hospital by analyzing the results of the outpatient pharmacy prescriptions review after medical reform from Jan. to May in 2013. METHODS: According to Prescription Management Methods, Management Criteria of Hospital Prescription Comment(trial)and others, the outpatient prescriptions of the first continuous five workdays in every month from Jan. to May in 2013, were evaluated by 4-levels review and the results were communicated by 4 levels feedback; irrational prescriptions were analyzed to put forward some suggestions. RESULTS: Of the total 186 944 prescriptions reviewed, 648 prescriptions were irrational with rational rate of 99.65% in average. Compared with average rational rate of prescription (93.18%) before medical reform (Jul-Nov. 2012), rational rate of prescription increased significantly; there was statistical significance (P〈0.05). The main irrational type were improper indication(25.37% ), and improper usage and dosage (48.70%). CONCLUSIONS: The rational rate of prescription is increased significantly, but we still should strengthen the intervention of inappropriate prescriptions by much more method, to promote the clinical use of drugs.
出处 《中国药房》 CAS CSCD 2013年第46期4355-4357,共3页 China Pharmacy
关键词 处方点评 四级点评 四级反馈 合理用药 Prescription review 4-levels review 4-levels feedback Rational drug use
  • 相关文献

参考文献4

二级参考文献15

共引文献167

同被引文献52

  • 1廖晓玲,金星,叶亚琳,曹洋,黎海英,王艾军.儿科门诊合理应用抗生素难点分析[J].中国药房,2005,16(6):441-442. 被引量:31
  • 2史惠卿,雍小兰,胡婷婷.临床医生对处方自动筛选系统中药物相互作用警示的依从性与信息质量的相关性分析[J].药学服务与研究,2006,6(6):427-429. 被引量:3
  • 3中华人民共和国卫生部.医院处方点评管理规范(试行)[S].卫医管发[2010]28号.
  • 4卫生部,国家中医药管理局,总后卫生部.抗菌药物临床应用指导原则[S],卫医发[2004]285号.2004,8.19.
  • 5中华人民共和国卫生部.卫生部关于印发《医院处方点评管理规范(试行)》的通知[S].卫医管发[2010]28号.2010-02-10.
  • 6中华人民共和国卫生部.处方管理办法[S].卫生部第53号部长令.2007-02-14.
  • 7中华人民共和国卫生部.卫生部办公厅关于抗菌药物临床应用管理有关问题的通知[S].卫办医政发[2009]38号.2009-03-23.
  • 8中华人民共和国卫生部办公厅.关于进一步开展全国抗菌药物临床应用专项整治活动的通知[S].卫办医政发〔2013〕37号.2013-05-06.
  • 9中华人民共和国卫生部.关于实行《抗菌药物临床应用指导原则》的通知[S].卫医发[2004]285号.2004-08-19.
  • 10Mofarrah R, Aberer W, Aberer E. Treatment of livedoid vasculopathy with alprostadil (PGE-1) : case report and review of published literature [ J ]. J Eur Acad Dermatol Venereol, 2013, 27(2): 252-254.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部